1 / 6

Pseudotumor Cerebri Market is expected to grow at CAGR 6.0% during the forecast period of 2019-2023

Pseudotumor Cerebri, also known as idiopathic intracranial hypertension, is a challenging condition with a rapidly increasing prevalence due to a close relation to obesity. Headache is the most common symptom of this condition, a persistent symptom in around 93% of patients, with pseudotumor cerebri, at the time of diagnosis.<br>

sagar000777
Download Presentation

Pseudotumor Cerebri Market is expected to grow at CAGR 6.0% during the forecast period of 2019-2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pseudotumor Cerebri Market is expected to grow at CAGR 6.0% during the forecast period of 2019-2023 SAMPLE FOR MORE INFO PREPARED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

  2. Pseudotumor Cerebri Market Market Highlights Pseudotumor Cerebri, also known as idiopathic intracranial hypertension, is a challenging condition with a rapidly increasing prevalence due to a close relation to obesity. Headache is the most common symptom of this condition, a persistent symptom in around 93% of patients, with pseudotumor cerebri, at the time of diagnosis. A number of factors such as increasing technological advancements, and growing prevalence of obesity, are propelling the growth of the global pseudotumor cerebri market. An increased incidence of pseudotumor cerebri, unmet medical needs, improving regulatory framework, increasing government assistance, increasing adoption rate of new technology, and improvement in funding and improved reimbursement policies are also boosting the growth of the market. However, cost of treatment, side-effects associated with surgical interventions, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the forecast period. Request For Sample Report: https://www.marketresearchfuture.com/sample_request/5709 www.marketresearchfuture.com

  3. Pseudotumor Cerebri Market Regional Analysis The Americas dominate the pseudotumor cerebri market owing to the rising occurrence of pseudotumor cerebri in this region, and technological advancements. According to the study suggested by International Ophthalmology Clinics in 2014, the annual incidence of idiopathic intracranial hypertension in the Western world is around 0.9 per 100,000 individuals and 3.5 per 100,000 in females, in between 15 to 44 years of age. It is also reported that the annual cost of idiopathic intracranial hypertension in the United States had been exceeded to USD 444 million due to frequent hospitalizations, and its inclination in young working-age adults which results in a significant loss of productivity Europe holds the second position in the pseudotumor cerebri market. It is found that the government support towards research & development, and favourable amendments in the reimbursement policies in the healthcare is likely to drive the European pseudotumor cerebri market. www.marketresearchfuture.com

  4. Pseudotumor Cerebri Market Segmentation The global pseudotumor cerebri market is segmented on the basis of diagnosis, treatment, and end user. By the diagnosis, the market is classified as fundoscopy, neuroimaging, lumbar puncture, and others. On the basis of the treatment, the market is classified as surgery, medication, and others. The surgery is further segmented into the spinal fluid shunt, optic nerve sheath fenestration (ONSF), dural venous sinus stenting, and bariatric surgery. The medication is further segmented into acetazolamide, topiramate, furosemide, steroids, others. By the end user, the market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others. Ask for discount: https://www.marketresearchfuture.com/check-discount/5709 www.marketresearchfuture.com

  5. ABOUT US MARKET RESEARCH FUTURE At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. www.marketresearchfuture.com

  6. MARKET RESEARCH FUTURE THANK YOU salesteam@marketresearchfuture.com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) www.marketresearchfuture.com

More Related